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OBJECTIVE: The aim of this study was to evaluate the effects of isoflavones on the skin of postmenopausal women.
DESIGN: A prospective study was performed with 30 postmenopausal women before and immediately after the end of treatment 
with 100 mg/day of an isoflavones-rich, concentrated soy extract for six months. A skin punch was performed in the gluteal region 
for sample collection before and immediately after the treatment program. Morphometric determination of epidermal thickness, the 
papillary index (wrinkling), and the amount of dermal elastic and collagen fibers was assessed. In addition, the number of blood 
vessels in the sample was also evaluated. The paired Student’s t-test was used for statistical analysis (P ≤ 0.05).
RESULTS: Isoflavone treatment resulted in a 9.46% increase in the thickness of the epidermis in 23 patients. In addition, the 
papillary index was reduced in 21 women. The papillary index was inversely proportional to skin wrinkling, i.e., there were a 
large number of papillae after treatment. The amount of collagen in the dermis was increased in 25 women (86.2%). In 22 women 
(75.8%) we observed that the number of elastic fibers increased. The number of dermal blood vessels was significantly increased 
in 21 women. 
CONCLUSION: Our data show that the use of a concentrated, isoflavone-rich soy extract during six consecutive months caused 
significant increases in epithelial thickness, the number of elastic and collagen fibers, as well as the blood vessels.
KEYWORDS: Isoflavones; Postmenopausal women; Skin; Blood vessels; Collagen fibers.
INTRODUCTION
Higher  socio-economic  development  and  the 
improvement of quality of life thanks to better medical care 
has led to a worldwide increase in life expectancy, especially 
for post-menopausal women.1
In this period, many skin alterations are observed that 
affect quality of life. Some of these changes seem to be 
associated mainly with the process of aging and sun exposure; 
others occur as a consequence of estrogen deficiency. The 
mechanisms involved seem to originate from the dermal and 
epidermal reduction of cellularity and collagen quantity and 
from skin thinning.2-4 Brincat et al.5 stated that this loss is 
faster in the initial years after menopause, when it reaches 
around 2.1% per year, causing a total cumulative loss of about 
30% of skin thickness in the first five years thereafter.
Skin is the main non-oral communication organ, the 
largest and one of the most complex in the body. It receives 
about 9% of the cardiac output and is involved in absorbing 
many different substances. It also possesses biochemical 
functions, such as steroid hormone metabolism,6 and can be 
impacted by certain systemic diseases.7
The skin is made up of an epithelial portion of 
ectodermic origin, the epidermis, and a conjunctive portion 
of mesodermic origin, the dermis. The epidermis contains 506
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keratinocytes, which form a keratinized stratified squamous 
epithelium. Many special types of cells are present in the 
skin, such as melanocytes, which produce the melanin 
pigment, Langerhans cells, which are part of the immune 
system, and Merckel cells, which represent mechanical 
receptors. The dermis contains a papillar layer, formed by a 
loose conjunctive tissue, and a reticular layer, formed by a 
dense non-modeled conjunctive tissue.8
Skin not only consists of cells, but also functions as 
an extracellular space that is often filled by a complex 
of components constituting the extracellular matrix. 
Morphologically, the extracellular matrix contains a large 
number of proteins and glycosaminoglycans, which organize 
themselves to form a net. Variations in the cellular and 
matrix quality and quantity, as well as their organization, 
are responsible for the morphological, functional and 
pathological diversity of skin tissue.9
Collagen and elastin are responsible for the structural 
and elastic qualities of skin. Collagen represents 70 to 80% 
of the dry weight of human skin, being the largest dermal 
component. It represents 30% of the total protein content in 
the human body.5 
Though a large number of collagen types have been 
described to date, the most abundant and well-studied 
types are I, II and III.10 Type I accounts for 90% of the 
total collagen in the body of a mammal. It is synthesized 
by fibroblasts and osteoblasts and forms thick and strong 
fibers.9
Fibroblasts exhibit receptors for estrogens and androgens. 
A decrease in estrogens affects glycosaminoglycans 
polymerization, which can eventually lead to a decrease in 
the collagen production rate.10,11 Decreased estrogen also 
causes granular degeneration and fragmentation of elastic 
fibers together with coalescence of cystic spaces. Under these 
conditions, a significant decrease in the number of small 
arterial vessels can be detected in the microcirculation.11 
As a consequence, thinning of the epidermal layer and the 
interpapillar cristae in the dermis-epidermis junction occurs.3 
Current treatment with natural estrogens results in 
morphological modifications to the aged skin, characterized 
mainly by an increased number of fibroblasts and 
glycosaminoglycans. The increase of the latter component 
suggests an increase in the water molecules of the dermal 
collagen component.12 However; estrogen therapy is not 
always feasible due to its side effects and contraindications. 
Therefore, many authors have evaluated the possibility of 
using phytohormones as an alternative to hormonal therapy 
after menopause, especially in patients for whom an estrogen 
treatment is not indicated.13-15 
Phytoestrogens are nonsteroidal substances of vegetal 
origin that exhibit agonistic and antagonistic estrogen 
activities.16,17 This behavior arises because they have a 
heterocyclic phenolic composition with structural similarities 
to the estrogens.16 
Isoflavones, particularly genistein, have a higher affinity 
for the β subtype of the estrogen receptor, which is present 
in bones, skin and the cardiovascular system, as opposed 
to the α subtype, which is found in the uterus and breast.17 
Some authors have observed that oral intake of 40 mg soy 
isoflavone aglycones per day improves the aging skin of 
middle-aged women as compared to a placebo group.18,19 
In rats, red clover isoflavones are effective in reducing skin 
aging induced by estrogen deprivation.9 However, the effect 
of isoflavones compared to estrogen on the skin remains 
unknown. 
This study was undertaken to address the scarcity of 
research to date regarding isoflavone effects on female 
postmenopausal skin.
MATERIALS AND METHODS
Thirty postmenopausal patients who attended the 
Ambulatório de Climatério do Departamento de Ginecologia 
e Obstetrícia da Faculdade de Medicina de Catanduva 
(FAMECA)* in the year 2005 were enrolled in our study. 
The study protocol was approved by the FAMECA Ethics 
Commission. All patients gave their informed consent prior 
to participation.
Women older than forty who had experienced amenorrhea 
for longer than one year and exhibited high circulating levels 
of gonadotrophins were identified as post-menopausal.1 
Patients undergoing hormone therapy as well as those 
with factors that may interfere with the medication were 
excluded.
In addition to the regular anamnesis and the general 
physical and gynecological examinations, a skin biopsy was 
taken. The biopsy was always taken in the gluteal region, 
in the external superior square with a 4 mm in extension 
conducted using rotatory movements, until it reached the 
hypodermis. After routine processing, the slides were 
stained by hematoxylin-eosin (HE) to study the thickness 
of the epidermis; by the Verhoeff stain, to identify elastic 
fibers; and by picrosirius red, to highlight collagen fibers. An 
immuno-histochemical procedure using the CD 34 antigen 
was employed as a blood vessel marker. 
The morphometric study consisted of a volumetric 
analysis  that  involved  point  counting  to  quantify 
representative areas of collagen and elastic fiber. In order 
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to strengthen the results assessment and to maintain the 
data within confidence intervals, we calculated the volume 
densities (VD) of the collagen and elastic fibers in a 
preliminary study involving three histological cuts. We 
derived this data from the ratio of the number of points 
reached by each structure (Pp) to the number of test-points 
(Tp), i.e. VD = Pp / Tp.20 After the volume density had been 
calculated for each structure studied, a nomogram was used 
for immediate visualization to determine the necessary 
number of points given a relative standard error of 5%.21 For 
the volumetric analysis of collagen and elastic fibers, 105 
and 3264 points were counted, respectively.
Direct reading was used for vessel counting, without the 
need for any device assistance. A vascular unit was identified 
by the presence of hazel colored cells bordering the luminal 
space. We analyzed ten fields per slide in order to count the 
number of vessels. 
Epidermal thickness and the papillary index were 
determined by light microscopy with a clear chamber 
(Leitz), which allowed visualization of the varied structures 
by means of image superposition. Using a 16x objective 
and a 10x ocular lens, the epidermal contour was printed 
on a sheet of paper using a standardized net as described by 
Merz.19 Alternating semi-circles formed sinusoidal parallel 
lines with equidistant points that were modified to create 100 
intersection points.
Epidermal thickness was calculated from the occupied 
area between the inner contour, which corresponds to the 
basal layer, and the outer contour of the corneus layer.
The epidermis wrinkling index was considered equivalent 
to the papillar index, expressed as the ratio of the outer 
contour line length of the corneus layer to the inner contour 
of the epidermis basal layer.
Statistical Analysis
The effects of isoflavone treatment were analyzed 
using the paired Student’s t-test; the Pearson’s correlation 
coefficient was also used to study the variables before and 
after treatment. In subsequent tables and figures, significant 
differences (P ≤ 0.05) are indicated by asterisks. The power 
calculation was 28 for a 90% confidence interval.
RESULTS
Of the 29 studied patients, 23 presented a 9.46% increase 
in epidermal thickness (P < 0.01). The epithelial thickness 
averaged 560.8 ± 4.4 µm before and 613 ± 4.6 µm after 
the six months of treatment (Table 1, Fig. 1). Though the 
epidermal papillar index (wrinkling) has been reported to 
decrease in women after concentrated soy extract therapy, we 
noted an increase in wrinkling of 10.4% ± 1.9% after therapy 
with concentrated soy extract. This index was inversely 
proportional to the number of dermal papillae. 
Dermal collagen quantification suggested that 25 women 
(86%) exhibited a significant rise (7.6 ± 1.5%) in the number 
of collagen fibers after treatment. The values were 152.0 ± 
2.2 and 163.0 ± 2.3 (no units) before and after therapy with 
concentrated soy extract, respectively (P < 0.01). In 22 of 
the women (75.8%), a 18.8 ± 4.8% (P < 0.01) increase in 
number of elastic fibers was detected after treatment. The 
average values were 525.4 ± 4.2 and 611.2 ± 4.6 (no units) 
before and after treatment, respectively. We observed that 21 
(72.4%) women presented a 20.2 ± 5.9% (P <0.01) increase 
in the number of dermal vessels after treatment. The average 
numbers of vessels were 64.2 ± 1.4 and 74.1 ± 1.6 before 
and after treatment, respectively.
DISCUSSION
Postmenopause is characterized by several changes due 
to a physiological reduction in the ovarian production of 
Table 1 – histological parameters in postmenopausal skin
Parameters Before treatment After treatment
epithelial thickness (µm) 560.8 ± 4.4 613 ± 4.6*
epidermal papillar index (%) 10.4 ± 1.9 14.7 ± 4.0*
dermal collagen (no units) 152.0 ± 2.2 163.0 ± 2.3*
elastic fibers (no units) 525.4 ± 4.2 611.2 ± 4.6*
dermal vessels (number per slide) 64.2 ± 1.4 1.1 ± 1.6*
*p<0.01 compared to data before treatment – paired Student’s t-test.
Figure 1 - Photomicrograph of a histological gluteal skin section from a 
patient before (A, C) and after (B, D) treatment with isoflavones. A - Note 
the absence of the dermal papilae and a thin epidermal layer. B - Note the 
increased epidermal thickness. C and D - Note the blood vessels. The ar-
rows indicate the dermal papillae, and “v” are the vessels. (A and B 250x; 
C and D 450x, H.E.)508
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steroidal hormones.22-24 This creates a hypoestrogen state 
that can provoke significant phenomena such as hot flashes, 
decreased libido, loss of bone mass and atrophy of the 
genitourinary tract and skin.17
Following the Raine-Fenning et al.25 study, several 
authors identified a progressive decrease in dermal collagen 
concentrations, skin drying and even skin atrophy after 
menopause. We note that these latter phenomena, related to 
the drop in circulating estrogens, manifest in a number of 
ways. In some postmenopausal women the changes occur 
slowly, but in others the onset can be very fast.26
To eliminate or at least minimize the deleterious 
effects of estrogen deficiency, estrogen therapy is not only 
directed at the early symptoms (hot flashes) but also aims 
to arrest certain well-known menopausal conditions such 
as osteoporosis and skin atrophy.11,27 Data in the literature 
has shown that long-term estrogen treatment is effective in 
increasing skin thickness in postmenopausal women.15, 28, 29 
Despite the known beneficial effects of hormonal 
therapy, compliance rates are low, ranging from 10 to 
30%.17, 30 Given this fact, alternative therapeutic options 
are required for women who do not accept or who have 
some contraindication to classical hormonal therapy in 
the postmenopausal period. Of the available alternatives, 
phytoestrogens (especially isoflavones) are often highlighted, 
with particular emphasis on concentrated, isoflavone-rich 
soy extracts.
Isoflavones appear to exhibit biological activities 
similar to estrogen because they are heterocyclic phenolic 
compounds with structural similarities to both natural and 
synthetic estrogens.31-33 
Certain authors have reported that isoflavone effects 
depend on the plasma concentrations of their corresponding 
aglycones, such as genistein and daidzein.34 In addition, 
we note that the metabolites of these substances may also 
exhibit biological activity. Among these, equol, the final 
product of daidzein biotransformation, has clear estrogen-
like activity and displays affinity for both the α and β 
estrogen receptors. Also, it is superior to other isoflavones 
with regards to antioxidant activity.35
Cai and Wei36 have demonstrated that ingesting soy 
isoflavone (genistein) for 30 days significantly increases the 
activity of the antioxidant enzyme superoxide dismutase in 
various mouse organs. The largest increases of antioxidant 
enzyme activity were observed in the intestine and on the 
skin. 
Many studies have shown that isoflavones may impact 
the skin.37,38 The results presented herein show an increase 
in the epidermal and dermal skin thickness after a six-
month treatment program with a concentrated soy extract at 
a dose of 100 mg per day. In addition to an increase in the 
epidermal thickness, we also found increases in the papillary 
index, quantity of collagen and elastic fibers, and number of 
dermal vessels.
Kotsopoulos et al.37 conducted a double-blind, placebo-
controlled study involving 94 postmenopausal women aged 
50 to 75 years. They each received an isoflavone-enriched 
high-protein diet. The study reported an enhancement in the 
moisture content of facial skin, with a significant decrease 
in drying after three months of treatment. By contrast, 
Tomaszewski et al.38 evaluated human skin fibroblasts in cell 
culture, and reported an increase in collagen production after 
treatment with isoflavones, although this effect was less than 
that induced by estrogen.
Despite minimal evidence supporting isoflavone action 
on skin, there are reports that genistein may exert protective 
effects on aging skin as well as reducing the risk of skin 
carcinoma induced by ultraviolet irradiation, an effect 
presumably related to the inhibition of dermal tyrosine 
kinases in animals.39 However, there is inconsistent evidence 
that this would happen in menopausal women.37
The effect of estrogens on the thickness of the skin 
epithelial layer is well understood. Fuchs et al.29 reported 
a 23% increase in epithelium thickness after six months 
of treatment with topical estrogens. In animals, Calil et 
al.40 have shown that treatment with equine conjugated 
estrogens increases the epithelial thickness of the skin of 
adult ovariectomized mice. Accordingly, isoflavones should 
improve the skin epithelium (thickness and papillar index) 
by binding to estrogen receptors, thereby promoting cellular 
proliferation.41
Besides epithelial cells, estrogen receptors are found 
in other skin components such as in fibroblasts. In these 
cells, estrogens act by reducing metalloprotease activity in 
the skin. Therefore, this should result in less degradation 
of skin collagen fibers during estrogen treatments.42 We 
emphasize that collagen is responsible for both skin structure 
and strength. In addition, estrogenic action enhances the 
concentration of glycosaminoglycans, thus elevating skin 
water content and consequently increasing skin turgor.43 Our 
results suggest an increase in the number of skin elastic and 
collagen fibers. This effect would presumably be mediated 
by the activation of the estrogen receptor, although the exact 
subtype that is activated cannot be defined at present.
Many clinical studies in postmenopausal women suggest 
that skin thickness is greater in those who have been treated 
with estrogens than in those who have not. This effect 
is more evident after at least one year of treatment,  44,45 
although this effect has also been shown with much shorter 
treatment durations.44 Conceivably, the increase in collagen 
content after treatment with concentrated soy extract could 
be explained by an estrogen-like action of isoflavones. 509
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As reported elsewhere, skin aging is not totally dependent 
on estrogen. Many other factors such as ultraviolet radiation 
(UV) can accelerate the degradation of skin components and 
the apoptosis of both epithelial and dermal cells.45
In animals, treatment with isoflavones offers protection 
against the initiation and promotion of photocarcinogens in 
the skin induced by UV radiation.37,46,47 Besides this, topical 
application of genistein can protect against the erythremia 
caused by UV radiation in humans.39 The mechanism of 
action of isoflavones on skin may not only be dependent 
on an estrogen-like mechanism, but might also involve the 
participation of antioxidants.39
Skin hydration depends on both the number of vessels 
and their responsiveness. In postmenopausal patients, 
the skin tends to progressively dry out and subcutaneous 
capillaries disappear. Though estrogens increase the 
concentrations of epidermal and vascular-endothelial 
growing factors, estrogenic therapy is unable to restore the 
cutaneous microvasculature after six months of treatment.48 
Skin vessel maintenance/growth mechanisms are probably 
related to a complex array of cellular factors, some of which 
may be independent of the estrogen receptor.
Finally, our data have shown that the administration 
of a concentrated soy extract for six months can provide 
definite benefits. We note improvements in skin health for 
the postmenopausal women in our study, mainly through 
increased epithelium thickness, elevated concentrations 
of collagen and elastic fibers, and an increased number 
of subcutaneous vessels. Presumably, these same effects 
could also protect skin against the deleterious effects of 
UV radiation. Isoflavone therapy is worthy of further 
investigation and should be compared to results obtained 
in the treatment of postmenopausal women with a standard 
replacement estrogenic therapy. 
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